Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid and Vitamin B12 Supplementation in Type 2 Diabetes
NCT02786823Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- May 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of folic acid and vitamin b12 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by AIIMS New Delhi. Primary endpoint: Glycated Hemoglobin at 8 weeks. Started May 2017; status: completed.
02
Drugs
folic acidvitamin b12
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02786823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786823.